Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Balow

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Hospital Practice (Office Ed.)|November 1, 1983
Steroids in immunologically mediated renal diseaseJ E Balow
In Vivo (Athens, Greece)|January 1, 1988
The nephropathy of systemic lupus erythematosusJ E Balow
Current Opinion in Nephrology and Hypertension|April 11, 2000
Progress in the treatment of proliferative lupus nephritisJ E Balow, H A Austin
Journal of Immunopharmacology|January 1, 1985
Immunosuppressive agents and plasmapheresis in immunological disordersG C Tsokos, J E Balow
The International Journal of Artificial Organs|September 1, 1982
Plasmapheresis in systemic lupus erythematosus: facts and perspectivesJ E Balow, G C Tsokos
Lupus|January 12, 1999
Renal biopsy in lupus nephritisJ P Grande, J E Balow
Seminars in Nephrology|June 16, 2000
Treatment of lupus nephritisH A Austin, J E Balow
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1983
Henoch-Schönlein nephritis: prognostic features and the challenge of therapyH A Austin, J E Balow
Clinical Immunology and Immunopathology|February 1, 1983
Phenotypes of T lymphocytes in systemic lupus erythematosus: decreased cytotoxic/suppressor subpopulation is associated with deficient allogeneic cytotoxic responses rather than with concanavalin A-induced suppressor cellsG C Tsokos, J E Balow
Journal of Clinical & Laboratory Immunology|June 1, 1982
Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active diseaseG C Tsokos, J E Balow
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Hospital Practice (Office Ed.)|November 1, 1983
Steroids in immunologically mediated renal diseaseJ E Balow
In Vivo (Athens, Greece)|January 1, 1988
The nephropathy of systemic lupus erythematosusJ E Balow
Current Opinion in Nephrology and Hypertension|April 11, 2000
Progress in the treatment of proliferative lupus nephritisJ E Balow, H A Austin
Journal of Immunopharmacology|January 1, 1985
Immunosuppressive agents and plasmapheresis in immunological disordersG C Tsokos, J E Balow
The International Journal of Artificial Organs|September 1, 1982
Plasmapheresis in systemic lupus erythematosus: facts and perspectivesJ E Balow, G C Tsokos
Lupus|January 12, 1999
Renal biopsy in lupus nephritisJ P Grande, J E Balow
Seminars in Nephrology|June 16, 2000
Treatment of lupus nephritisH A Austin, J E Balow
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1983
Henoch-Schönlein nephritis: prognostic features and the challenge of therapyH A Austin, J E Balow
Clinical Immunology and Immunopathology|February 1, 1983
Phenotypes of T lymphocytes in systemic lupus erythematosus: decreased cytotoxic/suppressor subpopulation is associated with deficient allogeneic cytotoxic responses rather than with concanavalin A-induced suppressor cellsG C Tsokos, J E Balow
Journal of Clinical & Laboratory Immunology|June 1, 1982
Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active diseaseG C Tsokos, J E Balow
Pageof 16